Impetus Grants
Impetus Grants is a 501(c)(3) nonprofit program under Norn Group that provides up to $500,000 within 3 weeks to scientists pursuing high-risk, high-reward research in aging biology and longevity science.
- Company typePrivate
- Founded2021
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Impetus Grants does
Impetus Grants is a 501(c)(3) nonprofit grant-making program operated under Norn Group Inc., founded in 2021 and based in San Francisco. It deploys philanthropic donations as research grants of up to $500,000 per project to academic and independent scientists working on high-risk, high-reward questions in aging biology and longevity science. The organization positions itself as filling the gap between government funders (which it characterizes as too slow and risk-averse for speculative ideas) and venture-backed company formation (which it characterizes as too early-stage for some avenues of investigation), with a stated 3-week application-to-decision turnaround and approximately 1% overhead.
Its core offering is a recurring grant cycle, currently anchored by three completed rounds (145 projects, $34M+ cumulatively deployed, 237+ acknowledging publications including in Science, Cell, and Nature) plus an active fourth round, the AI-Enabling Datasets focused initiative, which funds open-source, AI-ready datasets covering organ-level and longitudinal measurements. Funded research areas span senolytic CAR-T cell therapy, single-cell aging atlases, rapamycin clinical trials (ERAP, VIBRANT), and aging biomarker validation. Pricing to recipients is effectively a standardized grant award; the organization earns no revenue in the commercial sense and is funded entirely by donations from named philanthropists and foundations, including a 2023 $10M joint commitment from Hevolution Foundation and Rosenkranz Foundation and a $15M AI-Enabling Datasets round with anchor matching from Robert Rosenkranz.
Impetus Grants firmographics
Firmographics- Name
- Impetus Grants
- Legal name
- Norn Group Inc.
- Website
- https://impetusgrants.org
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Impetus Grants is a 501(c)(3) nonprofit program under Norn Group that provides up to $500,000 within 3 weeks to scientists pursuing high-risk, high-reward research in aging biology and longevity science.
- Ownership category
- akta.pro rank
Impetus Grants industry classification
Industry- Product category
- Research Grant Funding
- NAICS
- Grantmaking Foundations (813211), Grantmaking and Giving Services (81321), Voluntary Health Organizations (813212)
- akta.pro primary industry
- Research & Science Grantmaking Foundations (BPAGAKAI)
- akta.pro secondary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
Keywords
Where Impetus Grants is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Impetus Grants business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Others
Revenue model
- Donations and Philanthropic Funding: Impetus Grants operates as a nonprofit organization funded entirely by donations from individual philanthropists and foundations. Major patrons include Juan Benet, Robert Rosenkranz, Hevolution Foundation, Vitalik Buterin, James Fickel, Fred Ehrsam, Michael Antonov, Jed McCaleb, Karl Pfleger, Molly Mackinlay, and Feruell. The organization received a $10 million commitment from Hevolution Foundation and Rosenkranz Foundation in 2023. Donations are used to provide grants of up to $500k to researchers in the longevity field.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Impetus Grants product offering
Product offeringCore offering
Impetus Grants is a 501(c)(3) nonprofit grant-making program that funds ambitious, high-risk longevity and aging-biology science by providing scientists with up to $500,000 per project, with funding decisions returned within three weeks. The program operates under Norn Group Inc., has deployed $34M+ across 145 projects, and runs focused thematic grant rounds (e.g., AI-Enabling Datasets) on top of its open application pipeline.
Product overview
Impetus Grants is a nonprofit grant program designed to fund ambitious longevity science that would not happen otherwise. It operates as a focused funding mechanism providing up to $500k within 3 weeks for scientists working on the most important problems in aging biology. The core Impetus Grants program is supplemented by focused grant rounds like the AI-Enabling Datasets initiative. Research programs span senolytic CAR-T therapy, foundations of aging cellular atlases, rapamycin clinical trials, and aging biomarker validation. To date, $34M+ has been deployed across 145 projects with approximately 1% organizational overhead.
Differentiator
Problem solved
Functional benefit
Products and services
- Impetus Grants Core Program Core grant-making program providing up to $500,000 in non-dilutive funding to individual scientists working on ambitious, high-risk longevity and aging-biology research projects, with a 3-week decision turnaround. Intended for researchers in academic and independent settings.
- AI-Enabling Datasets Focused Round Thematic focused round of grants dedicated to AI-Enabling Datasets and tooling for longevity research, with a $15M fundraising target. Aimed at AI/ML researchers and longevity scientists building datasets that support aging-biology research.
Quantifiable outcome
- 145 projects funded across three rounds with $34M+ deployed
- +4 more outcomes
Companies that use Impetus Grants
Customer profileSegments1 record
Ideal customer profiles2 records
Impetus Grants technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Impetus Grants partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- AI/ML Research CommunitycoreImpetus Grants' AI-Enabling Datasets round is designed to generate high-quality datasets for the longevity field to leverage AI for medical breakthroughs. The round combines reviewers in biology and AI, and requires that resulting data is open-source and formatted for ingestion by major AI model architectures.
Scale indicators9 records
Recent moves4 records
Expansion highlights4 records
Impetus Grants competitors and assessment
Company assessmentDirect peers
- Methuselah Foundation: Philanthropic organization backing longevity research and prizes (e.g., Mprize), comparable as a donor-funded engine seeding ambitious longevity science.
- American Federation for Aging Research (AFAR): Long-standing nonprofit funding biomedical aging research through grant programs — comparable mission and grantmaking mechanism, with a more established but slower-moving operating model.
- Hevolution Foundation: A major philanthropic foundation funding aging and longevity research with billion-dollar-scale commitments, including a $10M commitment to Impetus itself. Directly comparable as a science-focused grantmaker in the same aging-biology space.
- SENS Research Foundation: Nonprofit that funds and conducts research into the biology of aging and rejuvenation, operating in the same high-risk, translational longevity niche as Impetus Grants.
- VitaDAO: Decentralized autonomous organization pooling crypto-holder capital to fund longevity research — close overlap with Impetus's crypto-major-patron donor base and patient-capital-for-longevity thesis.
- Longevity Science Foundation: Crypto-aligned nonprofit funding longevity research and access, with a similar donor base philosophy (open, patient capital for high-impact longevity science) as Impetus.
Broad incumbents
- Calico Labs: Alphabet-backed longevity research organization with substantially greater resources, pursuing similar biology-of-aging questions though via internal R&D rather than external grantmaking.
- Altos Labs: Well-capitalized biotech focused on cellular rejuvenation, operating in the same longevity biology domain as the researchers Impetus funds, but as a company rather than a grantmaker.
- NIH National Institute on Aging (NIA): The dominant federal funder of aging research, explicitly referenced by Impetus as the traditional mechanism their program complements — directly comparable as an aging-research grantmaking entity.
Emerging players
- Buck Institute for Research on Aging: Independent research institute focused on aging biology; comparable in scientific focus but primarily operates its own labs rather than funding external researchers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Impetus Grants social profiles
Digital presenceImpetus Grants financial estimates
Financial estimateRevenue estimate
Valuation estimate
Impetus Grants leadership team
Management profileNumber of profiles
Impetus Grants funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Impetus Grants M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Impetus Grants
What does Impetus Grants do?
Impetus Grants is a 501(c)(3) nonprofit grant-making program that funds ambitious, high-risk longevity and aging-biology science by providing scientists with up to $500,000 per project, with funding decisions returned within three weeks. The program operates under Norn Group Inc., has deployed $34M+ across 145 projects, and runs focused thematic grant rounds (e.g., AI-Enabling Datasets) on top of its open application pipeline.
Is Impetus Grants a public or private company?
Impetus Grants is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Impetus Grants founded?
Impetus Grants was founded in 2021. It employs 11 to 50 people.
Where is Impetus Grants based?
Impetus Grants is headquartered in San Francisco, United States, in the North America region.
How does Impetus Grants make money?
One revenue line is on record: donations and Philanthropic Funding.
Who are Impetus Grants's main competitors?
Direct peers on record are Methuselah Foundation, American Federation for Aging Research (AFAR), Hevolution Foundation, SENS Research Foundation, VitaDAO and Longevity Science Foundation. Broad incumbents are Calico Labs, Altos Labs and NIH National Institute on Aging (NIA). Buck Institute for Research on Aging is listed as an emerging player.
Does Impetus Grants have an API?
No public API is recorded for Impetus Grants.
What industry is Impetus Grants in?
Impetus Grants's product category is Research Grant Funding. Its primary akta.pro industry code is BPAGAKAI, Research & Science Grantmaking Foundations, with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813211.